Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Daria Gaut"'
Publikováno v:
Leukemia Research Reports, Vol 16, Iss , Pp 100260- (2021)
Tafasitamab (MOR208) is an Fc-enhanced, humanized, monoclonal antibody that targets CD19. The L-MIND (NCT02399085) trial, an open-label, single-arm, phase II study of Tafasitamab (TAFA) plus lenalidomide (LEN), reported progression-free survival of 1
Externí odkaz:
https://doaj.org/article/94a0208d3c074e2d91604c262a5bd363
Publikováno v:
Leukemia Research Reports, Vol 9, Iss , Pp 65-71 (2018)
Although rare, secondary clonal hematologic neoplasia may occur after successful therapy for acute promyelocytic leukemia (APL). These secondary clonal events may be considered therapy-related, but may also be due to an underlying background of clona
Externí odkaz:
https://doaj.org/article/48fd6088661741c1afd69a371703d7ff
Publikováno v:
Hematology Reports, Vol 11, Iss 2 (2019)
Secondary acute lymphoblastic leukemia (ALL) is a rare disease that has not been well characterized compared with secondary myelodysplastic syndrome or secondary acute myeloid leukemia. We present a report of two patients who developed ALL following
Externí odkaz:
https://doaj.org/article/cae9b2965ada453c855b1ba6a8aa7f2b
Publikováno v:
SAGE Open Medical Case Reports, Vol 7 (2019)
Reactive arthritis has been described infrequently in association with staphylococcal infections, both those secondary to Staphylococcus aureus and coagulase-negative staphylococci. We present a case of a 51-year-old male undergoing chemotherapy for
Externí odkaz:
https://doaj.org/article/a0444356f4b64874abac55bbe0b5e819
Publikováno v:
Case Reports in Medicine, Vol 2018 (2018)
Liver abscess is a rare but serious complication of Crohn’s disease. Patients with Crohn’s disease are at risk for pyogenic liver abscesses due to immunosuppressive therapy, fistulous disease, and intraabdominal abscesses. Inflammatory bowel dise
Externí odkaz:
https://doaj.org/article/7c1e72806329405d8aa55874b9790cc1
Autor:
Dong Yin, Wangrong G Yang, Jack Weissberg, Catherine B Goff, Weikai Chen, Yoshio Kuwayama, Amanda Leiter, Hongtao Xing, Antonie Meixel, Daria Gaut, Fikret Kirkbir, David Sawcer, P Thomas Vernier, Jonathan W Said, Martin A Gundersen, H Phillip Koeffler
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43891 (2012)
Nanosecond pulsed electric fields (nsPEF) induce apoptotic pathways in human cancer cells. The potential therapeutic effective of nsPEF has been reported in cell lines and in xenograft animal tumor model. The present study investigated the ability of
Externí odkaz:
https://doaj.org/article/b4aae9c2b5254419b1ea48d99254aad2
Publikováno v:
Leukemia & Lymphoma. 64:507-510
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60e14bc6c3e5a85458fc275923344f70
https://doi.org/10.1080/10428194.2022.2151839
https://doi.org/10.1080/10428194.2022.2151839
Autor:
Ajay Major, Jovian Yu, Navika D. Shukla, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie G Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Publikováno v:
Blood. 140:1328-1331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd21cab171f68ea4052fe7440b870b3
https://doi.org/10.1182/blood-2022-157829
https://doi.org/10.1182/blood-2022-157829
Autor:
Tamer Othman, Juan Penaloza, Shiliang Zhang, Claire E. Daniel, Daria Gaut, Caspian Oliai, Elizabeth A Brem, Abinav Baweja, Jane Ly, Jack Reid, Lauren Pinter-Brown, Matthew Lee, Haifaa Abdulhaq, Joseph Tuscano
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e947-e957
Managing double-expressor lymphomas (DEL) is controversial given the dearth of data and lack of standardized guidelines on this high-risk subset of lymphomas. No prospective and few retrospective studies limited by either their sample size or short f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500b2bd301fef0400c7faaaf7d2f0a78
https://doi.org/10.1016/j.clml.2022.06.013
https://doi.org/10.1016/j.clml.2022.06.013
Autor:
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J Voorhees, Sophie Gabrielle Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M Winter, Brian T. Hill, Radhika Bansal, Jose Caetano Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A Pophali, Asaad Trabolsi, Jonathan H Schatz, Marie Hu, Veronika Bachanova, Michael Slade, Nathan Singh, Nausheen Ahmed, Joseph P McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Publikováno v:
Blood Advances.
Checkpoint inhibitor (CPI) therapy with anti-PD-1 antibodies has been associated with mixed outcomes in small cohorts of aggressive B-cell lymphoma patients following CAR T-cell therapy failure. To more definitively define CPI therapy efficacy in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::857d0457d554011421daf5721f4a4201
https://doi.org/10.1182/bloodadvances.2023010016
https://doi.org/10.1182/bloodadvances.2023010016